Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
5.43
-1.06 (-16.33%)
Dec 27, 2024, 4:00 PM EST - Market closed
Camp4 Therapeutics Revenue
In the year 2023, Camp4 Therapeutics had annual revenue of $350.00K.
Revenue (ttm)
$350.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$5,469
Employees
64
Market Cap
109.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 350.00K | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAMP News
- 3 months ago - Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO - Renaissance Capital
- 3 months ago - Kaiser Permanente-backed biopharma CAMP4 files for US IPO - Reuters
- 3 months ago - CAMP4 Therapeutics IPO Registration Document (S-1) - SEC
- 3 months ago - CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders - GLOBE NEWSWIRE